EVMN
EvommuneN/ANYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
No composite grade available (requires momentum and value).
Posture
Unrated
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -3.7.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
9
Value
N/A
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-05-28 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade N/A · Unrated
Confidence Medium · Net Neutral
Target $54.00
Why
Momentum9 · Δ7d -3.7
ValueN/A · Δ7d -
SentimentN/A · Δ7d -
So what
Insufficient data coverage. Recheck when scores populate.
Lead driver: Momentum · See technicals
Momentum
9
100% active weight
Current posture
7d trendFlat
Δ7d
-3.7
Δ21d
-42.6
Value
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
No composite grade available (requires momentum and value).
Fundamentals (TTM)As of 2026-05-28
Fundamentals (TTM)
As of 2026-05-28
Market Cap
$840.31M
Beta
-
Shares Out
-
P/E (TTM)
-
P/S (TTM)
-
P/FCF (TTM)
-
Rev YoY
-
EPS YoY
-
Gross Margin
-
Op Margin
-
Net Debt
-
Current Ratio
-
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology